Given the high prevalence of cannabis use in patients with anxiety disorders and PTSD, and the high rate of symptom-coping motives cited by cannabis users with these disorders41, 42, we next sought to determine if this resilience-promoting effect of 2-AG was generalizable to a direct CB1R agonist. The gene discussed is CNR1; the disease is post-traumatic stress disorder.